Three Systemic Comorbidity Axes in Chronic Obstructive Pulmonary Disease: A Comparative Bibliometric Analysis Based on the Web of Science Core Collection, 2005-2026.
- 1Department of Respiratory Medicine, The Second Affiliated Hospital of Shenyang Medical College, Shenyang, Liaoning, People's Republic of China.
- 2Department of Respiratory Medicine, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning, People's Republic of China.
Abstract
Background
Multisystem comorbidities contribute to the burden of chronic obstructive pulmonary disease (COPD), but the comparative maturity, frontier evolution, and evidence gaps of major COPD comorbidity domains remain unclear.Objective
To map and compare three systemic COPD comorbidity axes: cardiometabolic, neuropsychiatric/cognitive, and musculoskeletal/nutritional/frailty.Methods
: English-language Articles and Reviews published from 2005 to 2026 were retrieved from the Web of Science Core Collection using common COPD and axis-specific terms. After field checking and deduplication, we analyzed publication trends, contributors, normalized Author Keywords, thematic structures, co-occurrence networks, temporal frontiers, and an exploratory evidence-gap map. A random sample of 100 records per axis was independently assessed for topical relevance, and annual axis-specific publication shares were calculated against a background COPD corpus. Records from 2026 were excluded from temporal comparisons because 2026 was incomplete.Results
Datasets included 5386 cardiometabolic, 1671 neuropsychiatric/cognitive, and 2124 musculoskeletal/nutritional/frailty records. The cardiometabolic axis had the largest literature base and a mature disease-risk factor-outcome structure. The neuropsychiatric/cognitive axis centered on depression, anxiety, cognitive impairment, and quality of life. The musculoskeletal/nutritional/frailty axis showed the highest within-axis growth ratio (1.88) and the largest increase in background-normalized publication share, from 2.41% to 3.17%. Random validation identified 266/300 records as topically relevant, with 94.3% inter-reader agreement. Excluding pulmonary-hypertension-only records did not change the cardiometabolic temporal pattern. Recent frontiers included machine learning, Mendelian randomization, prediction models, and NHANES-based analyses.Conclusion
These findings describe publication activity and knowledge structure rather than clinical comorbidity frequency, severity, or evidence certainty. The three axes showed distinct patterns of scale, expansion, thematic maturity, and methodological development. This framework may inform topic selection and study design, while the exploratory research directions can be evaluated in future longitudinal, causal, interventional, and implementation studies.
Related
- Comparative Real-World Effectiveness of Dupilumab, Mepolizumab, and Benralizumab in Patients with Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.
- Comparative Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors on Sepsis in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
- Comparative Effects of Different Mind-Body Exercises on Lung Function, Exercise Capacity, and Quality of Life in Adults with Stable Chronic Obstructive Pulmonary Disease: A Bayesian Network Meta-Analysis
- [Obstructive Sleep Apnea in Interstitial Lung Disease: an underdiagnosed comorbidity].
- Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis
BibTeX
@article{zhong2026three,
title = {{Three Systemic Comorbidity Axes in Chronic Obstructive Pulmonary Disease: A Comparative Bibliometric Analysis Based on the Web of Science Core Collection, 2005-2026.}},
author = {Lili Zhong and Zhaoshuang Zhong and Wenhui Ma and Zhuoyu Sun and Guixian Xiao and Yang Yu and Chaofan Cao},
journal = {International journal of chronic obstructive pulmonary disease},
year = {2026},
month = oct,
doi = {10.2147/copd.s633286},
url = {https://europepmc.org/article/MED/42921587},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Three Systemic Comorbidity Axes in Chronic Obstructive Pulmonary Disease: A Comparative Bibliometric Analysis Based on the Web of Science Core Collection, 2005-2026.
AU - Lili Zhong
AU - Zhaoshuang Zhong
AU - Wenhui Ma
AU - Zhuoyu Sun
AU - Guixian Xiao
AU - Yang Yu
AU - Chaofan Cao
PY - 2026
DA - 2026/10/19
JO - International journal of chronic obstructive pulmonary disease
DO - 10.2147/copd.s633286
UR - https://europepmc.org/article/MED/42921587
AB - Background Multisystem comorbidities contribute to the burden of chronic obstructive pulmonary disease (COPD), but the comparative maturity, frontier evolution, and evidence gaps of major COPD comorbidity domains remain unclear.Objective To map and compare three systemic COPD comorbidity axes: cardiometabolic, neuropsychiatric/cognitive, and musculoskeletal/nutritional/frailty.Methods : English-language Articles and Reviews published from 2005 to 2026 were retrieved from the Web of Science Core Collection using common COPD and axis-specific terms. After field checking and deduplication, we analyzed publication trends, contributors, normalized Author Keywords, thematic structures, co-occurrence networks, temporal frontiers, and an exploratory evidence-gap map. A random sample of 100 records per axis was independently assessed for topical relevance, and annual axis-specific publication shares were calculated against a background COPD corpus. Records from 2026 were excluded from temporal comparisons because 2026 was incomplete.Results Datasets included 5386 cardiometabolic, 1671 neuropsychiatric/cognitive, and 2124 musculoskeletal/nutritional/frailty records. The cardiometabolic axis had the largest literature base and a mature disease-risk factor-outcome structure. The neuropsychiatric/cognitive axis centered on depression, anxiety, cognitive impairment, and quality of life. The musculoskeletal/nutritional/frailty axis showed the highest within-axis growth ratio (1.88) and the largest increase in background-normalized publication share, from 2.41% to 3.17%. Random validation identified 266/300 records as topically relevant, with 94.3% inter-reader agreement. Excluding pulmonary-hypertension-only records did not change the cardiometabolic temporal pattern. Recent frontiers included machine learning, Mendelian randomization, prediction models, and NHANES-based analyses.Conclusion These findings describe publication activity and knowledge structure rather than clinical comorbidity frequency, severity, or evidence certainty. The three axes showed distinct patterns of scale, expansion, thematic maturity, and methodological development. This framework may inform topic selection and study design, while the exploratory research directions can be evaluated in future longitudinal, causal, interventional, and implementation studies.
SN - 1176-9106
SN - 1178-2005
ER -